1 week Ago By ABMN Staff
Prudential Financial Inc. lessened its stake in shares of AngioDynamics, Inc. ( NASDAQ:ANGO – Free Report ) by 70.
3% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 28,366 shares of the medical instruments supplier’s stock after selling 67,000 shares during the quarter. Prudential Financial Inc.
owned approximately 0.07% of AngioDynamics worth $260,000 as of its most recent filing with the Securities and Exchange Commission. Several other institutional investors have also recently added to or reduced their stakes in the company.
SBI Securities Co. Ltd. purchased a new stake in shares of AngioDynamics during the fourth quarter worth about $28,000.
R Squared Ltd purchased a new stake in AngioDynamics in the 4th quarter worth approximately $49,000. US Bancorp DE grew its stake in AngioDynamics by 1,938.0% in the 4th quarter.
US Bancorp DE now owns 6,705 shares of the medical instruments supplier’s stock worth $61,000 after acquiring an additional 6,376 shares during the period. SG Americas Securities LLC raised its stake in AngioDynamics by 21.3% during the fourth quarter.
SG Americas Securities LLC now owns 16,102 shares of the medical instruments supplier’s stock worth $147,000 after purchasing an additional 2,832 shares during the period. Finally, Intech Investment Management LLC acquired a new position in shares of AngioDynamics in the 4th quarter valued at $152,000. Institutional investors and hedge funds own 89.
43% of the company’s stock. Wall Street Analyst Weigh In Separately, HC Wainwright reaffirmed a “buy” rating and issued a $16.00 target price (up from $15.
00) on shares of AngioDynamics in a research report on Monday. AngioDynamics Trading Down 3.2 % NASDAQ ANGO opened at $9.
24 on Friday. The stock has a market cap of $373.91 million, a P/E ratio of -1.
64 and a beta of 0.52. The company’s fifty day simple moving average is $9.
83 and its 200-day simple moving average is $8.94. AngioDynamics, Inc.
has a 52 week low of $5.47 and a 52 week high of $13.50.
AngioDynamics ( NASDAQ:ANGO – Get Free Report ) last issued its quarterly earnings data on Wednesday, April 2nd. The medical instruments supplier reported $0.03 EPS for the quarter, topping analysts’ consensus estimates of ($0.
13) by $0.16. The firm had revenue of $72.
00 million for the quarter, compared to analyst estimates of $70.30 million. AngioDynamics had a negative net margin of 79.
38% and a negative return on equity of 7.26%. The company’s quarterly revenue was down 4.
3% compared to the same quarter last year. On average, research analysts expect that AngioDynamics, Inc. will post -0.
37 EPS for the current fiscal year. Insider Buying and Selling at AngioDynamics In other news, SVP Warren Nighan, Jr. sold 4,060 shares of the firm’s stock in a transaction that occurred on Thursday, January 16th.
The shares were sold at an average price of $12.31, for a total transaction of $49,978.60.
Following the completion of the sale, the senior vice president now owns 41,817 shares of the company’s stock, valued at approximately $514,767.27. This trade represents a 8.
85 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink . 5.
40% of the stock is owned by insiders. AngioDynamics Profile ( Free Report ) AngioDynamics, Inc, a medical technology company, engages in the design, manufacture, and sale of medical, surgical, and diagnostic devices for the use in treating peripheral vascular disease, and oncology and surgical settings in the United States and internationally. The company offers Auryon Atherectomy system that is designed to deliver an optimized wavelength, pulse width, and amplitude to remove lesions while preserving vessel wall endothelium.
Further Reading Want to see what other hedge funds are holding ANGO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for AngioDynamics, Inc. ( NASDAQ:ANGO – Free Report ).
Receive News & Ratings for AngioDynamics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AngioDynamics and related companies with MarketBeat.com's FREE daily email newsletter ..
